The levels of IL-17 gene expression among 190 patients with depression were higher compared to 100 healthy individuals, while the mean mRNA expression of the immunoregulatory Foxp3 was considerably reduced in patients suffering from depressive disorders compared to the control group (54). This evidence concerns the gene IL17A and depressive symptom measurement.